Aherne Emily A, Fenlon Helen M, Shields Conor J, Mulsow Jurgen J, Cronin Carmel G
1 Department of Radiology, Mater Misericordiae Hospital, Dublin 7, Ireland.
2 Department of Colorectal Surgery, Mater Misericordiae Hospital, Dublin, Ireland.
AJR Am J Roentgenol. 2017 Mar;208(3):531-543. doi: 10.2214/AJR.16.16646. Epub 2017 Jan 11.
The purpose of this article is to discuss the role of the radiologist in the treatment of peritoneal cancer, with focus placed on advanced treatment options and selection of patients with resectable disease for whom complete cytoreduction can be achieved.
Peritoneal cancers traditionally have been associated with significant morbidity and universal mortality; however, the management of such cancers has evolved substantially. Advanced treatment options, including cytoreductive surgery and intraperitoneal chemotherapy, are associated with significantly improved long-term patient survival. To ensure that patients benefit from aggressive multimodality treatments, the radiologist plays a pivotal role in the multidisciplinary team to ensure careful patient selection, identifying individuals with resectable disease for whom complete cytoreduction can be achieved.
本文旨在探讨放射科医生在腹膜癌治疗中的作用，重点关注晚期治疗方案以及对可切除疾病且能够实现完全细胞减灭的患者的选择。
传统上，腹膜癌与高发病率和普遍的死亡率相关；然而，此类癌症的管理已发生了显著演变。包括细胞减灭术和腹腔内化疗在内的晚期治疗方案与患者长期生存率的显著提高相关。为确保患者从积极的多模式治疗中获益，放射科医生在多学科团队中发挥着关键作用，以确保仔细选择患者，识别出可切除疾病且能够实现完全细胞减灭的个体。
